| ASSET | YEAR | % RETURN |
|---|---|---|
Iteris (ITI) | 2024 | 5,303.88% |
LENZ Therapeutics (LENZ) | 2024 | 1,948.76% |
Fitell Corporation Ordinary Shares (FTEL) | 2024 | 1,469.08% |
Red Cat (RCAT) | 2024 | 979.78% |
Dave (DAVE) | 2024 | 945.64% |
Root (ROOT) | 2024 | 940.69% |
Quantum Computing (QUBT) | 2024 | 728.58% |
Dogness International Corp Class A (DOGZ) | 2024 | 723.36% |
Nano Nuclear Energy Inc Common Stock (NNE) | 2024 | 619.72% |
Innodata (INOD) | 2024 | 467.38% |
Intuitive Machines (LUNR) | 2024 | 458.17% |
Destiny Tech100 (DXYZ) | 2024 | 432% |
Chromadex (CDXC) | 2024 | 425.35% |
Corvus Pharmaceuticals (CRVS) | 2024 | 416.18% |
Mesoblast (MESO) | 2024 | 410.65% |
AudioEye (AEYE) | 2024 | 395.88% |
Redwire (RDW) | 2024 | 374.83% |
Hyliion (HYLN) | 2024 | 360.24% |
Willis Lease Finance (WLFC) | 2024 | 346.14% |
ASP Isotopes Inc Common Stock (ASPI) | 2024 | 322.65% |
Emergent Biosolutions (EBS) | 2024 | 319.15% |
Cango (CANG) | 2024 | 298.99% |
Capricor Therapeutics (CAPR) | 2024 | 284.87% |
Harrow Health (HROW) | 2024 | 276.88% |
Clover Health Investments (CLOV) | 2024 | 267.37% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
